Having joined 5AM Ventures in 2003, it is a wonder how Mr. Scott Rocklage was able to make managing partner in 2004. Mr. Scott Rocklage has contributed a lot to the medical world. In fact, he has been part of the health care management in which he demonstrated some very important strategic skills as a manager.
Similarly, this has led him to see the approval of some drugs in the FDA. Moreover, Dr. Scott Rocklage has been a part of multiple drug trials, where he contributed to the inventions in the medical world as well.
Dr. Scott Rocklage has also been involved in some scholarly discoveries in the medical world. This includes him being the inventor or co-inventor in over thirty patents in the United States of America.
Additionally, he has been able to be part of more than one hundred peer reviewed publications. Interestingly, Dr. Rocklage was a student at the University of California, Berkeley. Now, he conducted his research in Richard Schrock’s laboratory during his completion of his PhD program.
Furthermore, Dr. Scott Rocklage works with all people in all walks in life. During one of the interviews, he states that he works with entrepreneurs of all kinds so that they are able to get new improved ideas that they introduce to the medical world.
His confidence on their chances of making more inventions to completely eliminate cancer is very encouraging. The primary reason for his discoveries is to improve human health.
Dr. Rocklage’s leadership abilities have been seen from the many companies he has been able to lead in. For instance, he was the Chairman and CEO of Cubist Pharmaceuticals at some point and also the President and CEO of Nycomed Salutar in another instance.
He has also served as a Board Chairman of Relypsa and and Novira. Today, he is the Board Chairman of Rennovia, Kinestral, Cidara, Epirus and Pulmatrix.
One of the greatest lessons learnt from Dr. Rocklage is that one should never be afraid of taking risks. It is through them that the best things happen.